Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood
肾细胞癌患者接受免疫检查点抑制剂治疗后的临床结果与血液中活化的CD8 T细胞数量激增有关。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2022-004803.
Jennifer Wilkinson Carlisle,Caroline S Jansen,Maria Andrea Cardenas,Ewelina Sobierajska,Adriana Moon Reyes,Rachel Greenwald,Luke Del Balzo,Nataliya Prokhnevska,Omer Kucuk,Bradley C Carthon,Patrick Connor Mullane,Adeboye Osunkoya,Deborah Baumgarten,Fares Hosseinzadeh,Scott Wilkinson,Ross Lake,Adam G Sowalsky,Yuan Liu,Viraj A Master,Mehmet A Bilen,Haydn Kissick
肾癌
细胞生物学
肿瘤
免疫/内分泌
T细胞
CD8
Checkpoint
T细胞